CoChat

Elobixibat and its potential role in chronic idiopathic constipation

Open access
Acosta, Andres, Camilleri, Michael · 2014 · Therapeutic Advances in Gastroenterology

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Chronic idiopathic constipation is highly prevalent among adults. Bile acids (BAs) and the enterohepatic BA circulation modulate colonic secretion and motility that affect transit. BAs in the colon have a dual action as osmotic and stimulant agents. Newer agents, such as elobixibat (A3309), an inhibitor of the ileal BA transporter, have the potential to improve significantly the management of chronic constipation, with minimal adverse effects. Elobixibat modulates the enterohepatic BA circulation, enhancing the delivery of BAs to the colon where they induce secretory and motor effects. Secondary effects of the inhibition of BA absorption are reduced activation of the farnesoid X receptor, decreased secretion of fibroblast growth factor-19 into the portal circulation, and increased BA synthesis. This review focuses on the role of BAs, the enterohepatic BA circulation, and an ileal BA transporter inhibitor (elobixibat) in chronic constipation.

Overview

Integrity signals

Registry

Crossref · 10.1177/1756283x14528269

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 45 references

Research works printed but not linked: 1

  1. Gillberg P., Dahlstrom M., Starke I., Ostlund-Lindqvist A. (2010) The IBAT inhibition by A3309 a potential mechanism for the treatment of constipation. Gastroenterol Clin North Am 138: S224.

Cited by

See all 91

Metadata

Authors
Acosta, A., & Camilleri, M.
Affiliations
Mayo Clinic (US)
Venue
Therapeutic Advances in Gastroenterology
Published
2014-03-27
Volume
7
Issue
4
Pages
167-175
ISSN
  • 1756-283X (ISSN-L)
  • 1756-2848
OpenAlex
W2057872155
Cited by
91
References
45
Citations by year
2026: 5 · 2025: 5 · 2024: 7 · 2023: 5 · 2022: 12 · 2021: 6 · 2020: 13 · 2019: 7 · 2018: 13 · 2017: 5 · 2016: 6 · 2015: 5 · 2014: 1
FWCI
0.93
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Therapeutic Advances in Gastroenterology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK092179, T32DK007198)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
Keywords
elobixibat, chronic idiopathic constipation, bile acids, enterohepatic circulation, farnesoid X receptor, FGF19, colonic secretion, colonic motility, bile acid synthesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Elobixibat and its potential role in chronic idiopathic constipation. https://app.cochat.ai/papers/10.1177/1756283x14528269
The paper
Acosta, A., & Camilleri, M. (2014). Elobixibat and its potential role in chronic idiopathic constipation. Therapeutic Advances in Gastroenterology. https://doi.org/10.1177/1756283x14528269

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.